Vericel (VCEL) Change in Accured Expenses (2010 - 2026)
Vericel (VCEL) reported Change in Accured Expenses of -$5.3 million for Q1 2026, up 7.9% on a YoY basis from -$4.9 million in Q1 2025, and down 383.43% sequentially from $1.9 million in Q4 2025.
Vericel (VCEL) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Change in Accured Expenses data on file, last reported at -$5.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 7.9% year-over-year to -$5.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 125.64% YoY), and the FY2025 full-year result was $1.1 million, up 816.11% from the prior year.
- Change in Accured Expenses eased to -$5.3 million in Q1 2026, from $1.9 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $3.6 million in Q4 2023 to a low of -$5.7 million in Q1 2025.
- A 5-year average of -$207875.0 and a median of $75500.0 in 2022 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 6770.45% in 2025, while the deepest fall reached 10694.44% in 2025.
- Tracing VCEL's Change in Accured Expenses over 5 years: stood at $97000.0 in 2022, then surged by 3597.94% to $3.6 million in 2023, then decreased by 23.67% to $2.7 million in 2024, then tumbled by 32.1% to $1.9 million in 2025, then plunged by 383.43% to -$5.3 million in 2026.
- Business Quant data shows VCEL's Change in Accured Expenses at -$5.3 million in Q1 2026, $1.9 million in Q4 2025, and $1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | -5.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.27 Mn |
| Mar 31, 2026 | -5.27 Mn |
| Dec 31, 2025 | 1.86 Mn |
| Dec 31, 2025 | 1.86 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 3.02 Mn |
| Jun 30, 2025 | 3.02 Mn |
| Mar 31, 2025 | -5.72 Mn |
| Mar 31, 2025 | -5.72 Mn |
| Dec 31, 2024 | 2.74 Mn |
| Dec 31, 2024 | 2.74 Mn |
| Sep 30, 2024 | -2.99 Mn |
| Sep 30, 2024 | -2.99 Mn |
| Jun 30, 2024 | 44,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 54,000.00 |
| Mar 31, 2024 | 54,000.00 |
| Dec 31, 2023 | 3.59 Mn |
| Dec 31, 2023 | 3.59 Mn |